[Hernández-Ruiz E] Servei de Dermatologia, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain. Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Hernández-Muñoz I, Andrades E] Group of Inflammatory and Neoplastic Dermatological Diseases, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. [Masferrer E] Department of Dermatology, Hospital Universitari Mútua de Terrassa, Barcelona, Spain. [Ferrándiz-Pulido C, García-Patos V] Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Gimeno J] Servei de Patologia, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2020-08-03T09:19:04Z
2020-08-03T09:19:04Z
2019-01-01
Metastasis; Fibrosis; Cutaneous squamous cell carcinoma
Metástasis; Fibrosis; Carcinoma cutáneo de células escamosas
Metàstasi; Fibrosi; Carcinoma cutani de cèl·lules escamoses
Although desmoplasia has been associated with poor prognoses in cutaneous squamous cell carcinoma, little attention has been paid to the patterns of fibrosis. This study aimed to examine the different stromal fibrotic patterns as markers of metastatic risk. We performed a multicenter retrospective study that included 102 cutaneous squamous cell carcinomas (52 non-metastatic and 50 metastatic carcinomas). Clinical and histopa-thological data were registered. The fibrotic reaction pattern was classified as mature, intermediate or immature depending on the presence of keloid-like collagen and myxoid stroma. The immature pattern (areas characterized by myxoid changes with no inflammation) was observed in 18 samples and its presence was significantly associated with immuno-suppression, budding, desmoplasia, perineural invasion, anatomic level, tumoural depth and metastatic risk in the multivariate analysis. Our findings suggest that the presence of an immature myxoid fibrotic pattern, which can be easily identified by routine hematoxylin-eosin staining, is strongly associated with metastatic risk.
This work has been supported by grant PI15/00236 from Fondo de Investigación Sanitaria (FIS), Fondo Europeo de Desarrollo Regional (FEDER), Instituto de Salud Carlos III, Ministerio de Sanidad, and the ‘‘Xarxa de Bancs de Tumours”.
Article
Versió publicada
Anglès
Carcinoma basocel·lular; Fibrosi; Prognosi; DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Carcinoma, Squamous Cell; /secondary; DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Fibrosis; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis; ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::carcinoma de células escamosas; /secundario; ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::fibrosis; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::Diagnóstico::Pronóstico
Acta Dermato-Venereologica
Acta Dermato-Venereologica;99(1)
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3025
info:eu-repo/grantAgreement/ES/PE2013-2016/PI%2F00236
Attribution-NonCommercial 4.0 International
http://creativecommons.org/licenses/by-nc/4.0/
Articles científics - HVH [3439]